James M Daly - Net Worth and Insider Trading
James M Daly Net Worth
The estimated net worth of James M Daly is at least $1 Million dollars as of 2024-05-16. James M Daly is the Director of Halozyme Therapeutics Inc and owns about 20,503 shares of Halozyme Therapeutics Inc (HALO) stock worth over $930,631. James M Daly is the Director of Madrigal Pharmaceuticals Inc and owns about 1,198 shares of Madrigal Pharmaceuticals Inc (MDGL) stock worth over $260,170. James M Daly is also the EVP, Chief Commercial Officer of Incyte Corp and owns about 3,521 shares of Incyte Corp (INCY) stock worth over $200,274. Besides these, James M Daly also holds ACADIA Pharmaceuticals Inc (ACAD) . Details can be seen in James M Daly's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that James M Daly has not made any transactions after 2024-04-02 and currently still holds the listed stock(s).
Transaction Summary of James M Daly
James M Daly Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James M Daly owns 6 companies in total, including Halozyme Therapeutics Inc (HALO) , ACADIA Pharmaceuticals Inc (ACAD) , and Madrigal Pharmaceuticals Inc (MDGL) among others .
Click here to see the complete history of James M Daly’s form 4 insider trades.
Insider Ownership Summary of James M Daly
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HALO | Halozyme Therapeutics Inc | 2023-08-14 | director |
ACAD | ACADIA Pharmaceuticals Inc | 2020-05-11 | director |
MDGL | Madrigal Pharmaceuticals Inc | 2024-04-02 | director |
2021-07-01 | director | ||
2014-06-20 | director | ||
2015-06-23 | Exec. VP & Chief Comm. Officer |
James M Daly Latest Holdings Summary
James M Daly currently owns a total of 4 stocks. Among these stocks, James M Daly owns 20,503 shares of Halozyme Therapeutics Inc (HALO) as of August 14, 2023, with a value of $930,631 and a weighting of 66.9%. James M Daly owns 1,198 shares of Madrigal Pharmaceuticals Inc (MDGL) as of April 2, 2024, with a value of $260,170 and a weighting of 18.7%. James M Daly also owns 3,521 shares of Incyte Corp (INCY) as of June 23, 2015, with a value of $200,274 and a weighting of 14.4%. The other 1 stocks ACADIA Pharmaceuticals Inc (ACAD) have a combined weighting of 0% among all his current holdings.
Latest Holdings of James M Daly
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HALO | Halozyme Therapeutics Inc | 2023-08-14 | 20,503 | 45.39 | 930,631 |
MDGL | Madrigal Pharmaceuticals Inc | 2024-04-02 | 1,198 | 217.17 | 260,170 |
INCY | Incyte Corp | 2015-06-23 | 3,521 | 56.88 | 200,274 |
ACAD | ACADIA Pharmaceuticals Inc | 2020-05-11 | 0 | 14.85 | 0 |
Holding Weightings of James M Daly
James M Daly Form 4 Trading Tracker
According to the SEC Form 4 filings, James M Daly has made a total of 3 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Halozyme Therapeutics Inc is the sale of 20,000 shares on August 14, 2023, which brought James M Daly around $874,600.
According to the SEC Form 4 filings, James M Daly has made a total of 1 transactions in Madrigal Pharmaceuticals Inc (MDGL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Madrigal Pharmaceuticals Inc is the sale of 32,489 shares on April 2, 2024, which brought James M Daly around $8 Million.
According to the SEC Form 4 filings, James M Daly has made a total of 0 transactions in Incyte Corp (INCY) over the past 5 years. The most-recent trade in Incyte Corp is the sale of 11,691 shares on June 23, 2015, which brought James M Daly around $1 Million.
More details on James M Daly's insider transactions can be found in the Insider Trading History of James M Daly table.Insider Trading History of James M Daly
- 1
James M Daly Trading Performance
James M Daly Ownership Network
Ownership Network List of James M Daly
Ownership Network Relation of James M Daly
James M Daly Owned Company Details
What does Halozyme Therapeutics Inc do?
Who are the key executives at Halozyme Therapeutics Inc?
James M Daly is the director of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include SVP & Chief Technical Officer Michael J. Labarre , director & President and CEO Helen Torley , and SVP & Chief Financial Officer Nicole Labrosse .
Halozyme Therapeutics Inc (HALO) Insider Trades Summary
Over the past 18 months, James M Daly made 1 insider transaction in Halozyme Therapeutics Inc (HALO) with a net sale of 20,000. Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 225,862 shares made by Michael J. Labarre , a net sale of 251,061 shares made by Helen Torley , and a net sale of 30,000 shares made by Matthew L. Posard .
In summary, during the past 3 months, insiders sold 60,000 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 60,000 shares. During the past 18 months, 549,448 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 549,448 shares.
Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Halozyme Therapeutics Inc Insider Transactions
James M Daly Mailing Address
Above is the net worth, insider trading, and ownership report for James M Daly. You might contact James M Daly via mailing address: Incyte Corporation Experimental Station, Rte 141 & Henry Clay Rd. Bldg E336, Wilmington De 19880.